How to buy Thermo Fisher Scientific stock - 05 March

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Thermo Fisher Scientific stock

Own Thermo Fisher Scientific stock in just a few minutes.

Fact checked

Thermo Fisher Scientific Inc is a diagnostics & research business based in the US. Thermo Fisher Scientific shares (TMO) are listed on the NYSE and all prices are listed in US Dollars. Thermo Fisher Scientific employs 80,000 staff and has a trailing 12-month revenue of around USD$32.2 billion.

How to buy shares in Thermo Fisher Scientific

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Thermo Fisher Scientific. Find the stock by name or ticker symbol: TMO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Thermo Fisher Scientific reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Thermo Fisher Scientific, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Thermo Fisher Scientific. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Thermo Fisher Scientific share price

Use our graph to track the performance of TMO stocks over time.

Thermo Fisher Scientific shares at a glance

Information last updated 2021-03-03.
52-week rangeUSD$249.8022 - USD$532.3223
50-day moving average USD$492.7167
200-day moving average USD$465.4856
Wall St. target priceUSD$567.06
PE ratio 28.9543
Dividend yield USD$0.88 (0.19%)
Earnings per share (TTM) USD$15.96

Buy Thermo Fisher Scientific shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get two free stock valued between $2.50 and $250
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
TradeStation
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Tastyworks
$0
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Interactive Brokers
$0
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Thermo Fisher Scientific stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Thermo Fisher Scientific under- or over-valued?

Valuing Thermo Fisher Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Thermo Fisher Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Thermo Fisher Scientific's P/E ratio

Thermo Fisher Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 29x. In other words, Thermo Fisher Scientific shares trade at around 29x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Thermo Fisher Scientific's PEG ratio

Thermo Fisher Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7423. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Thermo Fisher Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Thermo Fisher Scientific's EBITDA

Thermo Fisher Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$10.2 billion.

The EBITDA is a measure of a Thermo Fisher Scientific's overall financial performance and is widely used to measure a its profitability.

Thermo Fisher Scientific financials

Revenue TTM USD$32.2 billion
Operating margin TTM 24.53%
Gross profit TTM USD$16 billion
Return on assets TTM 7.75%
Return on equity TTM 19.87%
Profit margin 19.79%
Book value $86.992
Market capitalisation USD$182 billion

TTM: trailing 12 months

Shorting Thermo Fisher Scientific shares

There are currently 2.8 million Thermo Fisher Scientific shares held short by investors – that's known as Thermo Fisher Scientific's "short interest". This figure is 13.7% up from 2.5 million last month.

There are a few different ways that this level of interest in shorting Thermo Fisher Scientific shares can be evaluated.

Thermo Fisher Scientific's "short interest ratio" (SIR)

Thermo Fisher Scientific's "short interest ratio" (SIR) is the quantity of Thermo Fisher Scientific shares currently shorted divided by the average quantity of Thermo Fisher Scientific shares traded daily (recently around 1.7 million). Thermo Fisher Scientific's SIR currently stands at 1.65. In other words for every 100,000 Thermo Fisher Scientific shares traded daily on the market, roughly 1650 shares are currently held short.

However Thermo Fisher Scientific's short interest can also be evaluated against the total number of Thermo Fisher Scientific shares, or, against the total number of tradable Thermo Fisher Scientific shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Thermo Fisher Scientific's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Thermo Fisher Scientific shares in existence, roughly 10 shares are currently held short) or 0.0072% of the tradable shares (for every 100,000 tradable Thermo Fisher Scientific shares, roughly 7 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Thermo Fisher Scientific.

Find out more about how you can short Thermo Fisher Scientific stock.

Thermo Fisher Scientific's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Thermo Fisher Scientific.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Thermo Fisher Scientific's total ESG risk score

Total ESG risk: 14.69

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Thermo Fisher Scientific's overall score of 14.69 (as at 01/01/2019) is excellent – landing it in it in the 15th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Thermo Fisher Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Thermo Fisher Scientific's environmental score

Environmental score: 2.11/100

Thermo Fisher Scientific's environmental score of 2.11 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Thermo Fisher Scientific is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Thermo Fisher Scientific's social score

Social score: 6.69/100

Thermo Fisher Scientific's social score of 6.69 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Thermo Fisher Scientific is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Thermo Fisher Scientific's governance score

Governance score: 3.38/100

Thermo Fisher Scientific's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Thermo Fisher Scientific is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Thermo Fisher Scientific's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Thermo Fisher Scientific scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Thermo Fisher Scientific has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Thermo Fisher Scientific Inc was last rated for ESG on: 2019-01-01.

Total ESG score 14.69
Total ESG percentile 14.7
Environmental score 2.11
Environmental score percentile 1
Social score 6.69
Social score percentile 1
Governance score 3.38
Governance score percentile 1
Level of controversy 2

Thermo Fisher Scientific share dividends

5%

Dividend payout ratio: 4.71% of net profits

Recently Thermo Fisher Scientific has paid out, on average, around 4.71% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.23% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Thermo Fisher Scientific shareholders could enjoy a 0.23% return on their shares, in the form of dividend payments. In Thermo Fisher Scientific's case, that would currently equate to about $0.88 per share.

While Thermo Fisher Scientific's payout ratio might seem low, this can signify that Thermo Fisher Scientific is investing more in its future growth.

Thermo Fisher Scientific's most recent dividend payout was on 15 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 15 March 2021 (the "ex-dividend date").

Have Thermo Fisher Scientific's shares ever split?

Thermo Fisher Scientific's shares were split on a 3:2 basis on 6 June 1996. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Thermo Fisher Scientific shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Thermo Fisher Scientific shares which in turn could have impacted Thermo Fisher Scientific's share price.

Thermo Fisher Scientific share price volatility

Over the last 12 months, Thermo Fisher Scientific's shares have ranged in value from as little as $249.8022 up to $532.3223. A popular way to gauge a stock's volatility is its "beta".

TMO.US volatility(beta: 0.81)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Thermo Fisher Scientific's is 0.8127. This would suggest that Thermo Fisher Scientific's shares are less volatile than average (for this exchange).

Thermo Fisher Scientific overview

Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; cancer diagnosis and medical research products; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics and chemicals; and pharma services. It has collaboration with WuXi Diagnostics and Mayo Clinic to develop antibodies tests; a strategic collaboration with Schrödinger, Inc.; an agreement with Daiichi Sankyo; collaboration with Northeastern University; and partnership with Boys & Girls Clubs of America. The company was incorporated in 1956 and is headquartered in Waltham, Massachusetts.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site